Atopic Dermatitis
7 competing products in clinical development for Atopic Dermatitis.
Pipeline by Phase
Phase 12
Phase 34
Approved1
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lebrikizumab | Eli Lilly | Approved | Recruiting | 85 |
| Lebrikizumab | Eli Lilly | Phase 3 | Completed | 77 |
| Baricitinib + Placebo + Topical corticosteroid | Eli Lilly | Phase 3 | Completed | 77 |
| Lebrikizumab | Eli Lilly | Phase 3 | Completed | 77 |
| Lebrikizumab | Eli Lilly | Phase 3 | Completed | 77 |
| BioLexa- Cohort 1 + BioLexa- Cohort 2 + Placebo + Gentamicin | Hoth Therapeutics | Phase 1 | Completed | 25 |
| ENS-002 | Concerto Biosciences | Phase 1 | Terminated | 25 |